glp 1 medication through insurance Medicare GLP-1 Drug Coverage Addressing GLP-1 Access and Adherence
Description
5 min read The FDA is putting its foot down on compounded GLP-1 drugswell, kind of
Hims & Hers Hims & Hers uses a similar membership-plus-medication model and the same $149 ongoing membership
It is a non-peptide small-molecule GLP-1 receptor agonist
Research suggests that even sub-therapeutic doses from a weight loss perspective produce measurable reductions in circulating IL-6 and TNF-alpha
Although it has been approved and prescribed in Spain since 2017, its fame seems to have exploded in recent months, leading to shortages and peoples obsession with getting their hands on the precious injections
